
-
How Trumponomics has shaken global markets
-
Sabalenka back to winnings ways in Berlin
-
Real Madrid star Mbappe hospitalised with stomach bug
-
Dropping Pope for India Test would have been 'remarkable', says England's Stokes
-
Climate change could double summer rainfall in the Alps: study
-
If Iran's Khamenei falls, what would replace him?
-
India's Bumrah aiming for three Tests out of five against England
-
Mutilation ban and microchips: EU lawmakers approve cat and dog welfare rules
-
Israel minister says Iran leader 'can no longer exist' after hospital hit
-
Thai PM clings on as crisis threatens to topple government
-
Govts scramble to evacuate citizens from Israel and Iran
-
Floods expected after Hurricane Erick makes landfall in western Mexico
-
Russia warns US against 'military intervention' in Iran-Israel war
-
Budapest mayor defies police ban on Pride march
-
Air India says plane 'well-maintained' before crash
-
Arctic warming spurs growth of carbon-soaking peatlands
-
Swiss central bank cuts interest rates to zero percent
-
Bordeaux-Begles 'underdogs' before Top 14 semis despite Champions Cup triumph
-
Gattuso convinced Italy can reach World Cup
-
Relieved Pakistanis recall 'horrifying nights' as Israel, Iran trade strikes
-
England v India: Three key battles
-
Stocks drop, oil gains as Mideast unrest fuels inflation fears
-
Israel's Netanyahu says Iran will 'pay heavy price' after hospital hit
-
France steps closer to defining rape as lack of consent
-
SpaceX Starship explodes during routine test
-
Belgrade show plots path out of Balkan labyrinth of pain
-
Thailand's 'Yellow Shirts' return to streets demand PM quit
-
Stocks drop after Fed comments as Mideast fears lift crude
-
Govts scramble to evacuate citizens from Israel, Iran
-
'Moving Great Wall': China unleash towering teen basketball star
-
Nippon Steel closes US Steel acquisition under strict conditions
-
Fundraising shift at NY pride as Trump scares off corporate donors
-
Kenyan LGBTQ community vogues despite threat of repressive law
-
Thai PM apologises as crisis threatens to topple government
-
Iran strikes Israel as Trump weighs US involvement
-
Shortages hit Nigeria's drive towards natural gas-fuelled cars
-
S.Africa's iconic protea flower relocates as climate warms
-
Thai PM faces growing calls to quit following Cambodia phone row
-
Mutilation ban and microchips: EU lawmakers vote on cat and dog welfare
-
Czechs sign record nuclear deal but questions remain
-
Suaalii fit to face Lions but O'Connor left out by Wallabies for Fiji Test
-
Myanmar's Aung San Suu Kyi marks 80th birthday in junta jail
-
Homeland insecurity: Expelled Afghans seek swift return to Pakistan
-
Mushroom murder suspect fell sick from same meal: defence
-
New Zealand coroner raises alarm over 'perilous' collision sport
-
Syrians watch Iran-Israel crossfire as government stays silent
-
India start new era without Kohli and Rohit against England
-
Asian stocks drop after Fed warning, oil dips with Mideast in focus
-
Juventus thump Al Ain in Club World Cup after Trump visit
-
Williams boost for Crusaders ahead of Chiefs Super Rugby showdown

Chinese medical portal censored after doubting herbal 'Covid remedy'
A popular Chinese medical information site has been censored by authorities for "violation of relevant laws and regulations", months after its criticism of a government-backed herbal Covid-19 treatment sent shares in a pharmaceutical giant tumbling.
DXY, which counts tech giant Tencent among its investors and runs a host of health-related services, previously questioned the value of Lianhua Qingwen, a herbal remedy marketed for fever and sore throats, as a Covid-19 treatment.
China approved the concoction -- made up of ingredients like honeysuckle and apricot seeds -- as a Covid-19 treatment in 2020, and it was distributed to Shanghai residents during the city's outbreak this year.
DXY's article was part of a wave of reports that caused shares in Lianhua Qingwen's producer -- one of China's largest traditional medicine companies -- to plunge.
The website has now been banned from posting on at least five of its Weibo social media accounts, with a notice at the top of its official page saying that due to "violation of relevant laws and regulations, this user is currently prohibited from posting".
DXY's official WeChat accounts, which typically publish multiple articles a day on medical topics, have not been updated since Monday.
The Weibo notice did not specify which regulations had been violated by DXY, which did not immediately respond to AFP's request for comment.
The Chinese government has increasingly promoted traditional medicine at home and abroad in recent years, often with nationalistic undertones.
DXY's coverage prompted criticism that it was targeting traditional Chinese medicine (TCM) in order to promote Western pharmaceuticals.
The United States and other countries have warned there is no evidence Lianhua Qingwen works to prevent or cure Covid-19, even as it has increasingly been promoted by government authorities in China and Hong Kong.
The US Food and Drug Administration has said it has not approved Lianhua Qingwen and that coronavirus-related claims about it were "not supported by competent and reliable scientific evidence".
Beijing issued its first white paper on TCM in 2016, laying out plans to build medicine centres and dispatch practitioners to developing countries in Africa and Southeast Asia.
President Xi Jinping has described TCM as a "treasure of Chinese civilisation" and has said that it should be given as much weight as other treatments.
Beijing's National Health Commission has also dispatched TCM practitioners as part of its medical reinforcement teams sent to fight Covid-19 outbreaks across the country.
H.Jarrar--SF-PST